Arovella Therapeutics Limited Current Assets

Arovella Therapeutics Limited (SUD.AX) currently reports a current assets of $7.3M as of June 2021. That compares with $2M in the prior-year period — up 260.9% year over year. Use the charts on this page to explore Arovella Therapeutics Limited's current assets history and peer comparisons.

Arovella Therapeutics Limited's current assets increased from $2M to $7.3M — a 260.9% year-over-year increase (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arovella Therapeutics Limited reported $7.3M in current assets as of June 2021. That compares with $2M in the prior-year period — up 260.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $7.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arovella Therapeutics Limited, and consider following SUD.AX for alerts when major investors trade the stock.

Arovella Therapeutics Limited is classified in the Healthcare sector. On current assets, it currently shows $7.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SUD.AX with unrelated industries.